Cor Vasa 2011, 53(8-9):486-489 | DOI: 10.33678/cor.2011.119

Two years of cooperation between Regional Cardiology Centre and the Centre for Pulmonary Hypertension: results

Daniel Foldyna1,*, Pavel Jansa2, Tomáš Snížek3, Zdeněk Klimsa1
1 Kardiovaskulární centrum, Nemocnice Jihlava
2 Centrum pro plicní hypertenzi, II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecné fakultní nemocnice, Praha
3 Plicní oddělení, Nemocnice Jihlava, Česká republika

Introduction: Pulmonary hypertension (PH) is a syndrome characterized by increased mean pulmonary artery pressure. It occurs as a part of many different heart and lung conditions but also as a consequence of primary disorder of pulmonary vessels. The prognosis of chronic PH is extraordinarily poor and, without timely treatment, the illness rapidly progresses to right-sided heart failure and death. We present a series of patients with PH resulting from two years of cooperation between our Regional Cardiology Centre and the Centre for Pulmonary Hypertension at the General Faculty Hospital, Prague. This series documents in part the epidemiologic situation concerning pulmonary artery hypertension (PAH) in the Vysočina region.

Patients and methods: Between 2009 and 2010, 6244 transthoracic echocardiographic examinations were performed in the Jihlava Cardiology Centre; 17 of the examined patients were referred to the expert centre. The major criterion for detailed evaluation was the presence of echocardiographic parameters of PH with an estimated pulmonary systolic pressure at rest above 35-40 mmHg after exclusion of postcapillary PH etiology.

Results: The series comprises 17 patients (53% men and 47% women; mean age of 61.2 ± 13.4 years). The diagnosis of PH was confirmed in all patients, with the mean pulmonary artery pressure 43.3 ± 10.6 mmHg. Mean 6 Minute Walk Test result was 321 ± 98 m. Mean BNP level in our series at diagnosis was 636 ± 403 ng/l. No patient was classified as NYHA I; 4, 11 and 2 patients (23.5%, 64.7%, 11.8%) were classified as NYHA II, III and IV, respectively. The most common etiologies were PAH (10 patients) and chronic thromboembolic pulmonary hypertension (4 patients). Estimated minimal prevalence of PAH is about 20 cases per million inhabitants.

Conclusion: Two years of experience with PH evaluation in our Regional Cardiology Centre underscores the need of systematic screening for PH and of regular follow-up of the affected patients. Better prognosis of PH is critically dependent on earlier and more precise diagnosis at all levels of care for these patients.

Keywords: Pulmonary hypertension; Echocardiographic diagnosis; Regional Cardiology Centre

Published: August 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Foldyna D, Jansa P, Snížek T, Klimsa Z. Two years of cooperation between Regional Cardiology Centre and the Centre for Pulmonary Hypertension: results. Cor Vasa. 2011;53(8-9):486-489. doi: 10.33678/cor.2011.119.
Download citation

References

  1. Riedel M. Klasifikace a nomenklatura plicní hypertenze. Kap Kardiol 2002;4:46-49.
  2. Jansa P, Popelová J, Al-Hiti H, et al. Chronická plicní hypertenze. Doporučený diagnostický a léčebný postup České kardiologické společnosti. Cor Vasa 2011;53:169-182. Go to original source...
  3. Jansa P, Ambrož D, Poláček P, et al. Plicní arteriální hypertenze. Cor Vasa 2009;51:455-461. Go to original source...
  4. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537. Go to original source... Go to PubMed...
  5. Natali D, Simonneau G, Humbert M, Montani D. Investigation of pulmonary hypertension. Rev Pneumol Clin 2008;64:151-161. Go to original source... Go to PubMed...
  6. Jansa P. Současný stav a perspektivy farmakoterapie plicní arteriální hypertenze. Interní Med 2010;12:182-185.
  7. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-1030. Go to original source... Go to PubMed...
  8. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007; 30:1103-1110. Go to original source... Go to PubMed...
  9. Fruchter O, Yigla M. Underlying aetiology of pulmonary hypertension in 191 patients: a single centre experience. Respirology 2008;13:825-831. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.